Some types of hearing loss can be fully reversed, while others are permanent with current medicine. The answer depends almost entirely on where the damage is: in the outer and middle ear, or deeper in the inner ear. Conductive hearing loss, caused by blockages or mechanical problems, is often fixable. Sensorineural hearing loss, caused by damage to the delicate sensory cells of the inner ear, is typically permanent, though a handful of exceptions exist and gene therapy is showing remarkable early results.
Conductive Hearing Loss Is Often Reversible
Conductive hearing loss happens when sound can’t travel properly through the ear canal, eardrum, or the tiny bones of the middle ear. The inner ear itself is fine; something is just blocking or dampening the signal before it gets there. Common causes include earwax buildup, fluid from ear infections, a hole in the eardrum, and a condition called otosclerosis where one of the middle ear bones stiffens and stops vibrating.
Because these are mechanical problems, they tend to have mechanical solutions. Removing impacted earwax can restore hearing immediately. Ear infections clear with treatment, and the fluid drains. A perforated eardrum can be surgically repaired. For otosclerosis, surgeons replace the frozen bone with a tiny prosthesis in a procedure called stapedectomy, which has strong outcomes: roughly 90% of patients achieve significant hearing improvement, and about 82% meet every measurable success criterion. These are some of the most reliable results in ear surgery.
Sensorineural Loss Is Usually Permanent
Sensorineural hearing loss originates in the inner ear, the hearing nerve, or (rarely) the brain itself. Most commonly, the problem is damage to hair cells, microscopic sensory cells in the cochlea that convert sound vibrations into electrical signals for the brain. Humans are born with about 15,000 of these cells per ear, and unlike birds or fish, we cannot regrow them once they’re destroyed.
Noise exposure, aging, certain medications, and genetics are the main culprits. Loud sound physically damages hair cells. Aging gradually degrades them. Chemotherapy drugs and some antibiotics can be toxic to them. Once enough hair cells die in a particular frequency range, that slice of hearing is gone. This is why age-related hearing loss and noise-induced hearing loss don’t come back on their own.
The Exceptions: When Sensorineural Loss Can Improve
A few specific situations break the “permanent” rule. The most important is sudden sensorineural hearing loss, where hearing drops rapidly in one ear over hours or days. This is treated as a medical emergency. High-dose steroids, started within 72 hours of onset, give the best chance of recovery. There’s a treatment window of about two to four weeks, and 80% of patients treated within two weeks show some degree of improvement. Among treated patients in clinical studies, about 87% experienced at least slight recovery, with roughly 39% achieving complete recovery.
Even without treatment, sudden hearing loss has a spontaneous recovery rate of 32 to 65%, which means some people improve on their own. But the odds are significantly better with prompt steroid treatment, which is why any sudden hearing change warrants urgent medical attention.
Hearing loss caused by certain ototoxic medications can also be partially reversible if the drug is stopped early enough, before the hair cells are permanently destroyed. The damage from these drugs sometimes begins with swelling or metabolic stress in the cells rather than outright cell death, leaving a window where stopping the medication allows partial recovery.
Preventing Damage Before It Happens
For children undergoing chemotherapy with cisplatin, one of the most ototoxic cancer drugs, the FDA approved a protective medication in 2022. Given intravenously after cisplatin infusions, it reduced the incidence of hearing loss from 68% to 39% in one trial and from 58% to 44% in another. This doesn’t reverse existing damage, but it represents a meaningful shift: for the first time, there’s an approved drug specifically designed to shield the inner ear during treatment that would otherwise harm it.
Hearing Aids and Cochlear Implants
For the majority of people with sensorineural hearing loss, the practical answer today isn’t reversal but compensation. Hearing aids amplify sound so that surviving hair cells can pick up what they’d otherwise miss. They work well for mild to moderate loss, but they don’t fix the underlying damage.
Cochlear implants go further. Rather than amplifying sound, they bypass damaged hair cells entirely and stimulate the hearing nerve directly with electrical signals. The brain learns to interpret these signals as sound. For people with severe to profound hearing loss, implants can restore the ability to understand speech, use the phone, and follow conversations. This isn’t technically reversing hearing loss, since the hair cells remain damaged, but the functional result is genuine hearing restoration. Implants are particularly effective in children, where early implantation supports normal language development.
Gene Therapy Is Producing Real Results
The most significant breakthrough in actual hearing reversal is happening right now in gene therapy trials for children born deaf due to a mutation in the OTOF gene. This gene provides instructions for making otoferlin, a protein essential for hair cells to transmit signals to the hearing nerve. Without it, the hair cells are intact but functionally silent.
Results from 19 children across four clinical trials have been striking. In one trial, children who started with profound hearing loss (unable to detect sounds below 95 decibels, roughly the volume of a motorcycle) improved to thresholds of 38 to 55 decibels within six months, putting them in the mild hearing loss range. Two children treated by a team at Southeast University achieved near-normal hearing within four months. A 10-month-old treated by Regeneron’s team improved from profound to moderate hearing loss by 12 weeks. Five children treated in both ears could localize where sounds were coming from in space, and their speech perception improved. No serious adverse events were reported.
Regeneron plans to file for FDA approval of its gene therapy by the end of 2025, which would make it the first approved treatment that genuinely reverses a form of genetic deafness. A second gene therapy candidate is in Phase I/II trials with a projected completion date of October 2028.
It’s worth being precise about what this means. OTOF mutations account for a small fraction of all genetic hearing loss, and the children in these trials had intact hair cells that simply couldn’t communicate. Gene therapy gave those cells the missing protein. For the far more common scenario of hair cells that are dead from noise, aging, or other causes, gene therapy in its current form wouldn’t help.
Hair Cell Regeneration: Early but Promising
The longer-term goal of hearing research is regrowing destroyed hair cells. In birds and reptiles, supporting cells in the inner ear naturally convert into new hair cells after damage. Mammals lost this ability somewhere in evolution, but researchers have found that blocking a specific signaling pathway (called Notch signaling) can coax mammalian supporting cells to become hair cells in laboratory settings.
A Phase I/IIa trial tested this approach in adults with mild to moderate sensorineural hearing loss. Participants received injections of a drug that blocks this pathway into the middle ear over two weeks. The trial was designed primarily to test safety, and the concept that regeneration could be triggered in a living human ear. This line of research is still in its earliest clinical stages, years from any potential approval, but it represents the clearest path toward reversing the most common forms of hearing loss.
What This Means for You
If your hearing loss is caused by earwax, infection, fluid, or a mechanical problem in the middle ear, reversal is likely and often straightforward. If you’ve experienced sudden hearing loss in one ear, get to a doctor within days, not weeks, because steroid treatment within the first 72 hours gives the best odds of recovery. If you have gradual sensorineural loss from noise exposure or aging, current medicine cannot reverse it, but hearing aids and cochlear implants can meaningfully restore function.
The landscape is changing faster than it has in decades. Gene therapy for specific genetic deafness is on the verge of FDA review, and hair cell regeneration has entered human trials. For now, though, the most powerful tool remains prevention: limiting noise exposure, using hearing protection, and addressing hearing changes early before they progress.